LifeMD Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +430.9% | -9.0% | -12.7% | +36.6% | -74.7% | +95.6% | +181.6% | -101.7% | – | – | -1,657.6% | – | |
| – | +11.9% | +8.2% | +9.0% | +11.7% | -0.4% | +4.3% | -173.4% | – | – | +19.7% | +2.1% | – | |
| – | +9.9% | -30.2% | +64.7% | -42.9% | +29.7% | -17.9% | -17.8% | +52.7% | -17.0% | -45.4% | +54.5% | – | |
| – | +430.9% | +176.7% | -33.0% | +40.7% | -182.3% | – | – | -109.4% | – | – | -151.0% | – | |
| – | -7.8% | -1.2% | +43.0% | +11.5% | -22.1% | +5.4% | +0.0% | +129.0% | -97.6% | -32.3% | +3,309.4% | – | |
| – | -7.8% | -1.2% | +43.0% | +11.5% | -22.1% | +5.4% | +29.0% | -2.8% | – | -112.0% | -20.5% | – | |
| – | 0.0% | +0.0% | 0.0% | +0.0% | 0.0% | +0.0% | 0.0% | +0.0% | 0.0% | +0.0% | 0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -100.0% | – | – | +712.1% | -100.0% | – | – | – | |
| – | +205.0% | -107.3% | -22.2% | +1.2% | +73.2% | -43.2% | +282.1% | +180.2% | -90.9% | -11.7% | +11.6% | – | |
| – | +428.1% | -89.0% | -69.8% | +218.1% | -237.1% | – | – | -778.1% | – | -117.8% | – | – | |
| – | – | -13.9% | -53.3% | +92.5% | -142.5% | – | +5,623.4% | -44.2% | -153.5% | – | -3,196.7% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.